Brandon D. Ayres, MD, joins Neda Shamie, MD, to discuss an FDA clinical trial that evaluated the safety and efficacy of a custom-manufactured artificial iris device (CustomFlex ArtificialIris, HumanOptics) for the treatment of congenital and acquired iris defects. Learn the results.
https://reachmd.com/programs/eye-on-ocular-health/fda-clinical-trial-results-for-an-artificial-iris-device/15507/
Iowa’s first artificial iris implant performed by Dr. Christopher Sales, M.D., at the University of Iowa.
Read MoreAs part of the Ophthalmology Journal podcast series, Lorraine M Provencher, MD interviews Michael E. Snyder, MD, to discuss the clinical trial and FDA approval of the CUSTOMFLEX® ARTIFICIALIRIS.
Read MoreEyeNet Magazine’s Rebecca Taylor interviews Brandon D. Ayres, MD, Kevin M. Miller, MD, and Michael E. Snyder, MD, to discuss CUSTOMFLEX® ARTIFICIALIRIS study results, surgical tips, and more.
Read MoreBrandon D. Ayres, MD; Barbara S. Fant, PharmD; Zachary C. Landis, MD; Kevin M. Miller, MD; R. Doyle Stulting, MD, PhD; Robert J. Cionni, MD; Nicole R. Fram, MD; Stephen Hamilton, MD; David R. Hardten, MD; Douglas D. Koch, MD; Samuel Masket, MD; Francis W. Price Jr., MD; Kenneth J. Rosenthal, MD; Michael E. Snyder, MD.
Read MoreVEO to Support the Aniridia Foundation International in its Efforts to Raise Awareness of Aniridia and Other Rare Diseases.
Read MoreDr. Chris Riemann presents a CUSTOMFLEX® ARTIFICIALIRIS case at the 2022 Telluride RetinaFilm Festival.
Read MoreDr. Richard Mackool, one of the study investigators from the CUSTOMFLEX® ARTIFICIALIRIS clinical trial: Safety and Effectiveness of the CustomFlex™ Artificial Iris Prosthesis for the Treatment of Iris Defects, mentions the CUSTOMFLEX® ARTIFICIALIRIS as one of the major medical breakthroughs that has happened in eye care in the last decade.
Read MoreRead about Louisiana’s first prosthetic iris implant performed by Dr. Satya Reddy, at Louisiana Cornea Specialists.
VEO to Support The Masket Foundation in its Efforts to Raise Awareness of Aniridia and Other Rare Diseases.
Read MoreCMS grants pass‐through payment status to the first and only FDA‐approved iris prosthesis, allowing greater access for patients.
Read MoreClick to watch the CBA coverage of a case from Dr. Andrew Shatz in Miami, Fl.
Read MoreClick to watch CBS coverage of a case by Dr. Brandon Ayres, at Wills Eye.
Read MoreOphthalmic surgeons and their patients now have access to the first FDA-approved iris prosthesis.
CINCINNATI, Ohio – September 27, 2018 – VEO Ophthalmics, LLC, today announced the launch of the CUSTOMFLEX® ARTIFICIALIRIS, the first iris prosthesis available in the United States…
Read MoreThe first stand-alone prosthetic iris has received regulatory approval in the United States. CustomFlex®ArtificialIris (HumanOptics) is a flexible silicone device indicated for adults and children with congenital aniridia or iris defects due to albinism, traumatic injury or surgical removal…
Read MoreThe U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye…
Read MoreVEO Ophthalmics
Phone: (513) 872-1330
Fax: (513) 961-2858
Email: info@veo-ophthalmics.com
Address: 10184 International Blvd.
West Chester, OH 45246
Copyright © 2018 VEO Ophthalmics, LLC.
Privacy Policy
